Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blue Scorpion is a U.S.-based health products company commercializing an FDA-listed over-the-counter homeopathic formula for temporary relief of pain and inflammation. Its flagship product, Blue Scorpion Pain & Inflammation Relief, combines homeopathic dilutions of Heteroctenus princeps venom, Apis mellifica, and Rhus toxicodendron and is sold directly to consumers through its e-commerce site. The commercial operations are run by Blue Scorpion Inc. in Florida, while affiliated entity Scorpion Venom Foundation LLC operates the company's education and research-transparency site focused on decentralized-science initiatives. The business appears to be positioned more as a consumer health and wellness brand than a traditional biotech drug developer, despite branding that references biotechnology and venom-derived ingredients. Publicly available evidence does not show a conventional clinical-stage pharmaceutical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blue Scorpion.